405 related articles for article (PubMed ID: 497518)
1. Electrophysiological actions of mexiletine (Kö1173) on canine Purkinje fibres and ventricular muscle.
Arita M; Goto M; Nagamoto Y; Saikawa T
Br J Pharmacol; 1979 Sep; 67(1):143-52. PubMed ID: 497518
[TBL] [Abstract][Full Text] [Related]
2. Electrophysiological effects of mexiletine (Kö1173) on ovine cardiac Purkinje fibers.
Weld FM; Bigger JT; Swistel D; Bordiuk J; Lau YH
J Pharmacol Exp Ther; 1979 Aug; 210(2):222-8. PubMed ID: 458628
[TBL] [Abstract][Full Text] [Related]
3. Electrophysiological actions of mexiletine on isolated rabbit atria and canine ventricular muscle and purkinje fibres.
Yamaguchi I; Singh BN; Mandel WJ
Cardiovasc Res; 1979 May; 13(5):288-96. PubMed ID: 476749
[TBL] [Abstract][Full Text] [Related]
4. Comparative electropharmacology of mexiletine, lidocaine and quinidine in a canine Purkinje fiber model.
Burke GH; Loukides JE; Berman ND
J Pharmacol Exp Ther; 1986 Apr; 237(1):232-6. PubMed ID: 3958966
[TBL] [Abstract][Full Text] [Related]
5. Effects of tetracyclic antidepressant drugs on the electrophysiological properties of canine cardiac Purkinje fibres.
Brennan FJ; Cassidy DM
Can J Cardiol; 1988 Sep; 4(6):281-6. PubMed ID: 3179792
[TBL] [Abstract][Full Text] [Related]
6. Effects of SG-75 (nicorandil) on electrical activity of canine cardiac Purkinje fibers: possible increase in potassium conductance.
Imanishi S; Arita M; Kiyosue T; Aomine M
J Pharmacol Exp Ther; 1983 Apr; 225(1):198-205. PubMed ID: 6300374
[TBL] [Abstract][Full Text] [Related]
7. Effects of the potassium channel activator, BRL 34915, on the action potential characteristics of canine cardiac Purkinje fibers.
Bril A; Man RY
J Pharmacol Exp Ther; 1990 Jun; 253(3):1090-6. PubMed ID: 2359018
[TBL] [Abstract][Full Text] [Related]
8. Frequency-dependent interactions of mexiletine and quinidine on depolarization and repolarization in canine Purkinje fibers.
Roden DM; Iansmith DH; Woosley RL
J Pharmacol Exp Ther; 1987 Dec; 243(3):1218-24. PubMed ID: 2447269
[TBL] [Abstract][Full Text] [Related]
9. Effects of therapeutic concentrations of diphenylhydantoin on transmembrane potentials of normal and depressed Purkinje fibers.
Rosen MR; Danilo P; Alonso MB; Pippenger CE
J Pharmacol Exp Ther; 1976 Jun; 197(3):594-604. PubMed ID: 932992
[TBL] [Abstract][Full Text] [Related]
10. Local anesthetic and negative chronotropic effects of diltiazem on canine cardiac Purkinje fibers.
Dangman KH; Ziam S; Miura DS
Am Heart J; 1989 Jun; 117(6):1271-7. PubMed ID: 2729055
[TBL] [Abstract][Full Text] [Related]
11. The cellular electropharmacology of mexiletine combined with sotalol in porcine papillary muscle and Purkinje fibre. II. Effects on action potential duration and refractoriness.
Berman ND; Wang LY; Ahmed A
Can J Cardiol; 1990 Nov; 6(9):423-30. PubMed ID: 2177360
[TBL] [Abstract][Full Text] [Related]
12. Effects of lidocaine and on slow response and depressed fast response action potentials of canine cardiac Purkinje fibers.
Brennan FJ; Cranefield PF; Wit AL
J Pharmacol Exp Ther; 1978 Feb; 204(2):312-24. PubMed ID: 621666
[TBL] [Abstract][Full Text] [Related]
13. Effects of dantrolene sodium on the electrophysiological properties of canine cardiac Purkinje fibers.
Salata JJ; Jalife J
J Pharmacol Exp Ther; 1982 Jan; 220(1):157-66. PubMed ID: 7053411
[TBL] [Abstract][Full Text] [Related]
14. Mechanisms of arrhythmias and of antiarrythmic activity, with special reference to mexiletine.
Carmeliet E
Acta Cardiol Suppl; 1980; (25):5-25. PubMed ID: 6246694
[No Abstract] [Full Text] [Related]
15. Electrophysiological effects of carocainide (770207) on canine ventricular muscle and Purkinje fibers.
Pourrias B; Santamaria R
Arch Int Pharmacodyn Ther; 1983 Sep; 265(1):85-95. PubMed ID: 6316863
[TBL] [Abstract][Full Text] [Related]
16. Electrophysiological effects of GYKI-23 107, a new antiarrhythmic compound, in isolated rabbit and canine cardiac preparations.
Varró A; Németh M; Rabloczky G; Papp JG; Szekeres L
J Cardiovasc Pharmacol; 1988 Mar; 11(3):251-7. PubMed ID: 2452917
[TBL] [Abstract][Full Text] [Related]
17. Electrophysiological effects of ACC-9358, a novel class I antiarrhythmic agent, on isolated canine Purkinje fibers and ventricular muscle.
Brown BS
J Pharmacol Exp Ther; 1989 Feb; 248(2):552-8. PubMed ID: 2918472
[TBL] [Abstract][Full Text] [Related]
18. Differential electrophysiologic effects of mexiletine on normal and hypoxic canine Purkinje fibers.
Burke GH; Berman ND
J Cardiovasc Pharmacol; 1985; 7(6):1096-100. PubMed ID: 2418294
[TBL] [Abstract][Full Text] [Related]
19. Direct and beta adrenergic blocking actions of nadolol (SQ 11725) on electrophysiologic properties of isolated canine myocardium.
Gibson JK; Gelband H; Bassett AL
J Pharmacol Exp Ther; 1977 Sep; 202(3):702-10. PubMed ID: 19621
[TBL] [Abstract][Full Text] [Related]
20. Electrophysiological actions of disopyramide phosphate on canine ventricular muscle and purkinje fibers.
Kus T; Sasyniuk BI
Circ Res; 1975 Dec; 37(6):844-54. PubMed ID: 1192576
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
